spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Scientists change kidney blood type, a potential advance for transplant recipients

Researchers have converted a blood type A kidney to a blood type O kidney and successfully transplanted it, they reported in Nature Biomedical Engineering, an advance that could reduce wait times for new organs and save lives.

Type O patients, who account for more than half of those on kidney waiting lists, can only receive organs from donors with type O blood, yet type O kidneys are often given to others because they are universally compatible. As a result, type O patients typically wait two to four years longer and many die waiting, the researchers said in a statement.

Traditional methods for overcoming blood-type incompatibility require days of intensive treatment to suppress the recipient’s immune system, while the new approach employs special enzymes to change the organ rather than the patient.

Hot this week

Novo Nordisk Lowers Full-Year Profit Guidance in New CEO’s Maiden Quarter

Wegovy-maker Novo Nordisk lowered its full-year profit forecast on...

Compass Pathways to expedite launch timing of its experimental depression therapy

Drug developer Compass Pathways said on Tuesday it is...

Pharma Investment to establish manufacturing facility at SOHAR Freezone

SOHAR Port and Freezone has signed a land lease...

Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up

Novo Nordisk and Pfizer have revised their bids for...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img